Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study

Journal of Genetic Counseling

Volumn 26, Issue 6, 2017, Pages 1270-1279

  Koeller, Diane R ^a,b   Uhlmann, Wendy R ^c   Carere, Deanna Alexis ^d   Green, Robert C ^c   Roberts, J Scott ^b,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Direct to consumer; DTC; Genetic counseling; Genetic counselors; Genetic testing; Health behavior; Personal genomic testing; Personalized medicine

Indexed keywords

ADULT; CHILD; CLINICAL ARTICLE; COLLEGE; CONSUMER; COUNSELOR; DOCTOR PATIENT RELATION; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HEALTH BEHAVIOR; HOUSEHOLD INCOME; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PERSONALIZED MEDICINE; SOCIAL STATUS; UNCERTAINTY; AGE; ATTITUDE TO HEALTH; DECISION MAKING; MIDDLE AGED; PSYCHOLOGY; SCREENING TEST; SEX FACTOR; UTILIZATION;

ADULT; AGE FACTORS; ATTITUDE TO HEALTH; DECISION MAKING; DIRECT-TO-CONSUMER SCREENING AND TESTING; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 85019220425     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-017-0106-7     Document Type: Article

References (38)

1. ACMG Board of Directors. (2015). Direct-to-consumer genetic testing: A revised position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 18(2), 207–208. doi:10.1038/gim.2015.190.
2. Ashida, S., Goodman, M. S., Stafford, J., Lachance, C., & Kaphingst, K. A. (2012). Perceived familiarity with and importance of family health history among a medically underserved population. Journal of Community Genetics, 3(4), 285–295. doi:10.1007/s12687-012-0097-x.
3. Bloss, C. S., Darst, B. F., Topol, E. J., & Schork, N. J. (2011). Direct-to-consumer personalized genomic testing. Human Molecular Genetics, 20(R2), R132–R141. doi:10.1093/hmg/ddr349.
4. Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. (2013). Impact of direct-to-consumer genomic testing at long term follow-up. Journal of Medical Genetics, 50(6), 393–400. doi:10.1136/jmedgenet-2012-101207.
5. Bowling, B. V., Acra, E. E., Wang, L., Myers, M. F., Dean, G. E., Markle, G. C., et al. (2008). Development and evaluation of a genetics literacy assessment instrument for undergraduates. Genetics, 178(1), 15–22. doi:10.1534/genetics.107.079533.
6. Bunnik, E. M., Janssens, A. C. J. W., & Schermer, M. H. N. (2015). Personal utility in genomic testing: Is there such a thing? Journal of Medical Ethics, 41(4), 322–326. doi:10.1136/medethics-2013-101887.
7. Carere, D. A., Couper, M. P., Crawford, S. D., Kalia, S. S., Duggan, J. R., Moreno, T. A., et al. (2014). Design, methods, and participant characteristics of the impact of personal genomics (PGen) study, a prospective cohort study of direct-to-consumer personal genomic testing customers. Genome Medicine, 6(12), 96. doi:10.1186/s13073-014-0096-0.
8. Carere, D. A., Kraft, P., Kaphingst, K. A., Roberts, J. S., & Green, R. C. (2016). Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing. Genetics in Medicine, 18(1), 65–72. doi:10.1038/gim.2015.34.
9. Caulfield, T., & McGuire, A. L. (2012). Direct-to-consumer genetic testing: Perceptions, problems, and policy responses. Annual Review of Medicine, 63, 23–33. doi:10.1146/annurev-med-062110-123753.
10. Chung, S., Mehta, K., Shumway, M., Alvidrez, J., & Perez-Stable, E. J. (2009). Risk perception and preference for prevention of Alzheimer’s disease. Value in Health, 12(4), 450–458. doi:10.14440/jbm.2015.54.A.
11. Darst, B. F., Madlensky, L., Schork, N. J., Topol, E. J., & Bloss, C. S. (2013). Perceptions of genetic counseling services in direct-to-consumer personal genomic testing. Clinical Genetics, 84(4), 335–339. doi:10.1111/cge.12166.
12. Dohany, D., Gustafson, S., Ducaine, W., & Zakalik, D. (2012). Psychological distress with direct-toconsumer genetic testing: a case report of an unexpected BRCA positibe test result. Journal of Genetic Counseling, 21(3), 399–401.
13. Food & Drug Administration. (2017). FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm551185.htm.
14. Francke, U., Dijamco, C., Kiefer, A. K., Eriksson, N., Moiseff, B., Tung, J. Y., & Mountain, J. L. (2013). Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing. PeerJ, 1, e8. doi:10.7717/peerj.8.
15. Furr, L. A., & Kelly, S. E. (1999). The genetic knowledge index: Developing a standard measure of genetic knowledge. Genetic Testing, 3(2), 193–199. doi:10.1089/gte.1999.3.193.
16. Gutierrez, A. (2013). Warning Letter. Retrieved from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm376296.htm.
17. Harris, A., Kelly, S. E., & Wyatt, S. (2013). Counseling customers: Emerging roles for genetic counselors in the direct-to-consumer genetic testing market. Journal of Genetic Counseling, 22(2), 277–288. doi:10.1007/s10897-012-9548-0.
18. Hock, K. T., Christensen, K. D., Yashar, B. M., Roberts, J. S., Gollust, S. E., & Uhlmann, W. R. (2011). Direct-to-consumer genetic testing: An assessment of genetic counselors’ knowledge and beliefs. Genetics in Medicine, 13(4), 325–332. doi:10.1097/GIM.0b013e3182011636.
19. Hudson, K., Javitt, G., Burke, W., Byers, P., & ASHG Social Issues Committee. (2007). ASHG Statement on Direct-to-Consumer Genetic Testing in the United States. American Journal of Human Genetics, 81(3), 635–637.
20. James, K. M., Cowl, C. T., Tilburt, J. C., Sinicrope, P. S., Robinson, M. E., Frimannsdottir, K. R., et al. (2011). Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clinic Proceedings, 86(10), 933–940. doi:10.4065/mcp.2011.0190.
21. Kalf, R. R. J., Mihaescu, R., Kundu, S., Knijff, P. D., Green, R. C., & Janssens, A. C. J. (2014). Variations in predicted risks in personal genome testing for common complex diseases. Genetics in Medicine, 16(1), 1–13. doi:10.1038/gim.2013.80.Variations.
22. Kaufman, D. J., Bollinger, J. M., Dvoskin, R. L., & Scott, J. A. (2012). Risky business: Risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling, 21(3), 413–422. doi:10.1007/s10897-012-9483-0.
23. Lehmann, L. S., Kaufman, D. J., Sharp, R. R., Moreno, T. A., Mountain, J. L., Roberts, J. S., & Green, R. C. (2012). Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 14(2), 268–273. doi:10.1038/gim.2011.59.
24. Leighton, J. W., Valverde, K., & Bernhardt, B. A. (2012). The general public’s understanding and perception of direct-to-consumer genetic test results. Public Health Genomics, 15(1), 11–21. doi:10.1159/000327159.
25. Lipkus, I. M., Samsa, G., & Rimer, B. K. (2001). General performance on a numeracy scale among highly educated samples. Medical Decision Making, 21, 37–44.
26. Mathews, R., Hall, W., & Carter, A. (2012). Direct-to-consumer genetic testing for addiction susceptibility: A premature commercialisation of doubtful validity and value. Addiction, 107(12), 2069–2074. doi:10.1111/j.1360-0443.2012.03836.x.
27. Meisel, S. F., Carere, D. A., Wardle, J., Kalia, S. S., Moreno, T. A., Mountain, J. L., et al. (2015). Explaining, not just predicting, drives interest in personal genomics. Genome Medicine, 7(1), 74. doi:10.1186/s13073-015-0188-5.
28. Molster, C., Charles, T., Samanek, A., & O’Leary, P. (2009). Australian study on public knowledge of human genetics and health. Public Health Genomics, 12(2), 84–91. doi:10.1159/000164684.
29. NSGC Executive Office. (2015). Direct Access to Genetic Testing. Retrieved from http://nsgc.org/p/bl/et/blogid=47&blogaid=22.
30. Ostergren, J. E., Gornick, M. C., Carere, D. A., Kalia, S. S., Uhlmann, W. R., Ruffin, M. T., et al. (2015). How well do customers of direct-to-consumer personal genomic testing services comprehend genetic test results? Findings from the impact of personal genomics study for the PGen study group. Public Health Genomics, 18(4), 216–224. doi:10.1159/000431250.
31. Powell, K. P., Christianson, C. A., Cogswell, W. A., Dave, G., Verma, A., Eubanks, S., & Henrich, V. C. (2012). Educational needs of primary care physicians regarding direct-to-consumer genetic testing. Journal of Genetic Counseling, 21(3), 469–478. doi:10.1007/s10897-011-9471-9.
32. Roberts, J. S., & Ostergren, J. (2013). Direct-to-consumer genetic testing and personal genomics services: A review of recent empirical studies. Current Genetic Medicine Reports, 1(3), 182–200. doi:10.1007/s40142-013-0018-2.
33. Smerecnik, C. M. R., Mesters, I., De Vries, N. K., & De Vries, H. (2011). Applying a theory-based framework to understand public knowledge of genetic risk factors: A case for the distinction between how-to knowledge and principles knowledge. Public Health Genomics, 14(4–5), 259–270. doi:10.1159/000294149.
34. Uhlmann, W. R., & Sharp, R. R. (2012). Genetic testing integration panels (GTIPs): A novel approach for considering integration of direct-to-consumer and other new genetic tests into patient care. Journal of Genetic Counseling, 21(3), 374–381. doi:10.1007/s10897-011-9468-4.
35. van der Wouden, C. H., Carere, D. A., Maitland-van der Zee, A. H., Ruffin, M. T., Roberts, J. S., & Green, R. C. (2016). Consumer perceptions of interactions with primary care providers after direct-to-consumer personal genomic testing. Annals of Internal Medicine. doi:10.7326/M15-0995.
36. Wade, C. H., & Wilfond, B. S. (2006). Ethical and clinical practice considerations for genetic counselors related to direct-to-Consuemr Marketing of Genetic Tests. American Journal of Medical Genetics Part C, 142C, 284–292. doi:10.1002/ajmg.c.
37. Ware, J., & Sherbourne, C. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
38. Wasson, K., Cherny, S., Sanders, T. N., Hogan, N. S., & Helzlsouer, K. J. (2014). Who are you going to call? Primary care patients’ disclosure decisions regarding direct-to-consumer genetic testing. Narrative Inquiry in Bioethics, 4(1), 53–68. doi:10.1353/nib.2014.0026.